Biocept Inc logo

BIOC - Biocept Inc News Story

$4.44 -0.3  -6.7%

Last Trade - 4:53pm

Sector
Healthcare
Size
Micro Cap
Market Cap £45.4m
Enterprise Value £36.9m
Revenue £19.5m
Position in Universe 5460th / 6856

BRIEF-Biocept Broadens Commercial Focus Of Its Target Selector Liquid Biopsy Platform To Include Urology Market Segment

Tue 26th March, 2019 12:13pm
March 26 (Reuters) - Biocept Inc  BIOC.O :
    * BIOCEPT BROADENS COMMERCIAL FOCUS OF ITS TARGET SELECTOR
LIQUID
BIOPSY PLATFORM TO INCLUDE UROLOGY MARKET SEGMENT
    * BIOCEPT INC - WILL BEGIN COMMERCIALIZING ITS RECENTLY
EXPANDED
PATHOLOGY PARTNERSHIP PLATFORM, EMPOWERTC, TO UROLOGY AND
UROPATHOLOGY PRACTICES

Source text for Eikon:  ID:nPnbvz1msa 
Further company coverage:  BIOC.O 

 (Reuters.Briefs@thomsonreuters.com)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.